Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Well-being enhancement company Healthways (HWAY - Analyst Report) recently revealed that it concluded the refinancing of its senior credit facilities. The earlier facilities were scheduled to terminate in December 2013. Those facilities have now been replaced with new ones comprising a 5-year term loan amounting to $200 million and an additional revolving credit facility worth $200 million.

The current facilities are now priced at Libor plus an additional margin of 250 basis points. The term loan is scheduled to amortize at 5% for the first 2 years, 7.5% in year 3 and 10% after that. The revolving credit facility had an initial amount of $106 million.   

The earnings guidance issued earlier by the company did not take into account the monetary effect of refinancing. Healthways forecasts that following the refinancing earnings per share will drop by about 4 cents in the current year. Consequently, the company is reducing its 2012 earnings per share guidance from an earlier range of 42 cents to 54 cents to a new band of 38 cents and 50 cents.    

The Healthways model encourages people to make favorable lifestyle changes that lead to enhanced well-being, reduced healthcare costs, improved performance and economic value. The company has invested in technology platforms that provide scalable support with large populations. It has tie-ups with a large portion of U.S. health plans and counts many millions of people in its customer base.

Due to its unique scalable business model, Healthways shares present a compelling, long-term investment opportunity although it may face many challenges in the short to medium term. Healthways is the leader in a strategically critical and rapidly evolving part of the health care services market. Its fitness program (SilverSneakers) for seniors is available at 14,000 centers across the U.S. and caters to several million eligible enrollees.

Healthways competes with Express Scripts (ESRX - Analyst Report), among others. We are currently Neutral on the stock, supported by a short-term Zacks #3 Rank (Hold).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%